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The authors of the original paper published with the same title [1] apologize for the error in the plot on 
Figure 5. 
The correct plot, statistics and explanation in Figure 5 on page 25 using the published data in the 
Appendix Table A1 and A2 by equation 3 are shown below. 
“In turn, the volume of distribution of marketed drugs could be modeled by the difference in the 
membrane and the protein binding of compounds as described by Equation 3 and shown in Figure 5 for the 
investigated compounds. There are only 40 compounds that have been included in the training set, the 
majority of the compounds were not included in the original model. That explains that the statistics are 
slightly worse (r2 = 0.76; root mean square error = 0.33 in the original model, while here the r2 = 0.65 and 
root mean square error = 0.40). “ 
It is considered as an excellent prediction of the in vivo behaviour of the compounds using only two 
measured biomimetic properties, namely the IAM membrane binding and the HSA protein binding (see the 
original paper for details). 
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